Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

A 69-year-old man with sinus infection and fainting spells was diagnosed with a rare kidney disease, treated with steroids and a specific drug, which improved his condition.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Sertraline, an antidepressant, may rarely cause hair loss.